Patents by Inventor James Gorham Boyd

James Gorham Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10588954
    Abstract: Described herein are multilayer films that include modified polypeptide epitopes from Plasmodium falciparum, specifically a modified T* epitope. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes the modified T* polypeptide epitope from a Plasmodium protozoan.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: March 17, 2020
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: James Gorham Boyd, Thomas J. Powell
  • Publication number: 20180221465
    Abstract: Described herein are multilayer films that include modified polypeptide epitopes from Plasmodium falciparum, specifically a modified T* epitope. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes the modified T* polypeptide epitope from a Plasmodium protozoan.
    Type: Application
    Filed: April 5, 2018
    Publication date: August 9, 2018
    Inventors: James Gorham Boyd, Thomas J. Powell
  • Patent number: 9975066
    Abstract: Layer by layer (“LBL”) construction of products by tangential flow filtration (TFF), or the like, is described, including computer controlled automation of such procedure for production of a multilayer coated core.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: May 22, 2018
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: James Gorham Boyd, Naveen Palath, Edwin Jonathan Cardenas
  • Patent number: 9968665
    Abstract: Described herein are multilayer films that include modified polypeptide epitopes from Plasmodium falciparum, specifically a modified T* epitope. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes the modified T* polypeptide epitope from a Plasmodium protozoan.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: May 15, 2018
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: James Gorham Boyd, Thomas J. Powell
  • Patent number: 9925252
    Abstract: Multilayer films are described that include polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: March 27, 2018
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20170128558
    Abstract: Described herein are multilayer films that include modified polypeptide epitopes from Plasmodium falciparum, specifically a modified T* epitope. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes the modified T* polypeptide epitope from a Plasmodium protozoan.
    Type: Application
    Filed: September 13, 2016
    Publication date: May 11, 2017
    Inventors: JAMES GORHAM BOYD, THOMAS J. POWELL
  • Patent number: 9487593
    Abstract: Multilayer films comprise polypeptide epitopes from RSV. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films include at least one designed peptide that includes one or more polypeptide epitopes from RSV. Specifically, the multilayer films include two polypeptide epitopes from RSV, such as an epitope that elicits a specific T-cell response such as a cytotoxic T-cell response, and an epitope that elicits a specific antibody response.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: November 8, 2016
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20160166669
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 16, 2016
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Patent number: 9302001
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: April 5, 2016
    Assignee: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20150343332
    Abstract: Layer by layer (“LBL”) construction of products by tangential flow filtration (TFF), or the like, is described, including computer controlled automation of such procedure for production of a multilayer coated core.
    Type: Application
    Filed: May 22, 2015
    Publication date: December 3, 2015
    Inventors: James Gorham Boyd, Naveen Palath, Edwin Jonathan Cardenas
  • Publication number: 20150030682
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Application
    Filed: October 8, 2014
    Publication date: January 29, 2015
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Patent number: 8883717
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand are described. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 11, 2014
    Assignee: Artificial Cell Technologies, Inc.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20130259946
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 3, 2013
    Applicant: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20120009254
    Abstract: Multilayer films comprise polypeptide epitopes from RSV. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films include at least one designed peptide that includes one or more polypeptide epitopes from RSV. Specifically, the multilayer films include two polypeptide epitopes from RSV, such as an epitope that elicits a specific T-cell response such as a cytotoxic T-cell response, and an epitope that elicits a specific antibody response.
    Type: Application
    Filed: July 7, 2011
    Publication date: January 12, 2012
    Applicant: ARTIFICIAL CELL TECHNOLOGIES, INC.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Publication number: 20090069287
    Abstract: The invention relates to substituted azacycloalka?e compounds useful in treating conditions of the Central Nervous System (CNS); a pharmaceutical composition comprising same; a method of treating such conditions and of treating conditions in which inhibition of beta-secretase is indicated.
    Type: Application
    Filed: November 10, 2006
    Publication date: March 12, 2009
    Inventors: James Gorham Boyd, Todd William Butler, Brian Thomas O'Neill